ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 152 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 9.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $218,000 | -67.5% | 6,726 | -59.1% | 0.01% | -81.7% |
| Q1 2020 | $670,000 | +60.3% | 16,439 | +142.5% | 0.06% | +215.8% |
| Q4 2019 | $418,000 | -21.4% | 6,778 | -7.1% | 0.02% | +5.6% |
| Q3 2019 | $532,000 | +29.4% | 7,299 | -12.1% | 0.02% | +38.5% |
| Q1 2017 | $411,000 | +47.3% | 8,300 | +80.4% | 0.01% | +85.7% |
| Q4 2016 | $279,000 | -35.3% | 4,600 | -29.2% | 0.01% | -30.0% |
| Q3 2016 | $431,000 | +3.1% | 6,500 | -47.7% | 0.01% | -9.1% |
| Q1 2016 | $418,000 | -19.1% | 12,431 | +8.6% | 0.01% | -21.4% |
| Q4 2015 | $517,000 | -22.5% | 11,451 | -32.2% | 0.01% | -39.1% |
| Q3 2015 | $667,000 | +54.0% | 16,885 | +141.9% | 0.02% | +76.9% |
| Q2 2015 | $433,000 | -43.7% | 6,981 | -43.2% | 0.01% | -48.0% |
| Q1 2015 | $769,000 | -8.8% | 12,289 | -17.8% | 0.02% | -13.8% |
| Q4 2014 | $843,000 | – | 14,948 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 327,929 | $9,218,000 | 3.24% |
| Parkman Healthcare Partners LLC | 107,911 | $3,033,000 | 0.89% |
| Global Alpha Capital Management Ltd. | 350,231 | $9,845,000 | 0.85% |
| MARATHON CAPITAL MANAGEMENT | 75,010 | $2,109,000 | 0.60% |
| TANG CAPITAL MANAGEMENT LLC | 100,000 | $2,811,000 | 0.56% |
| EMERALD ADVISERS, LLC | 354,045 | $9,952,000 | 0.38% |
| Sio Capital Management, LLC | 40,000 | $1,124,000 | 0.37% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 299,493 | $8,419,000 | 0.37% |
| Stonepine Capital Management, LLC | 26,060 | $733,000 | 0.30% |
| Mitsubishi UFJ Asset Management (UK) Ltd. | 23,000 | $646,530,000 | 0.29% |